Real-World Evidence
Our rigorous approach to qualitative research generates evidence that reveals how treatments actually perform in diverse, real-world settings. With expertise in focus groups, patient and expert interviews, we provide robust evidence that brings you closer to your product.
Making real-world evidence easy
CLINIGMA® delivers standalone patient and clinician interviews, and focus groups. These studies can be tailored as market research or IRB/EC-approved, depending on your objectives and patient factors. Our experienced team of scientific experts partner closely with you to develop clear objectives and guide you through every aspect of study design, data collection and reporting. We work with you to capture authentic patient voices across diverse real-world settings—where patients manage multiple comorbidities and adherence patterns vary, to provide you with contextual insights to understand how treatments perform beyond the clinical trial setting.
Our methodologically rigorous approach ensures real-world evidence meets the highest regulatory and scientific standards. Whether you are interested in patient experiences or key opinion leaders—we partner with you to deliver the strategic intelligence you require for better drug development.
Why choose CLINIGMA® for your real world evidence study
Global reach, local knowledge
Authentic insights across 35+ countries. Our worldwide network of 300+ researchers capture genuine patient experience data across diverse populations. We access hard-to-reach patients to provide comprehensive real-world perspectives. Our experienced local qualitative researchers have the cultural understanding to ensure authentic data collection anywhere in the world.
ICH-GCP standards for real-world research
In alignment with clients, our real-world evidence complies with ICH-GCP to safeguard potentially vulnerable patients and to provide clients peace of mind regarding data integrity and completeness. ICH-GCP trained researchers, comprehensive audit trails, and validated data collection protocols ensure your real-world evidence is trustworthy and fit for regulatory requirements, post-marketing studies, and scientific publication.
Rapid deployment & scalability
Our established global infrastructure enables rapid execution across multiple countries. Pre-qualified research teams, validated protocols, and streamlined regulatory processes mean we can deliver real-world insights when you need them—whether responding to safety signals, supporting market access discussions, or meeting regulatory timelines.
Robust analysis & transparent reporting
Our systematic approach to qualitative analysis creates transparent, auditable pathways from patient narratives to actionable insights. Complete documentation of analytical decisions, inter-rater reliability protocols, and comprehensive audit trails ensure your real-world evidence meets the highest regulatory standards.
Partnership & strategic insight
CLINIGMA® is your strategic partner in translating qualitative insights into actionable intelligence. Our experienced team understands drug development challenges and tailors research to align with your commercial and regulatory goals—from study design to final recommendations and regulatory submission.
Preferred partner
Trusted by leading pharmaceutical companies worldwide, our real-world evidence can support successesful regulatory submissions, market access strategies, and product lifecycle decisions. Our methodological expertise, quality standards, and commitment to listen to patients and clients have established CLINIGMA® as the preferred partner for patient-centered drug development.
Discover what your patients really experience
Let us help you capture real-world insights—for better treatments and commercial success.
© Copyright 2025
CLINIGMA® All rights reserved